Keyphrases
Platinum Drugs
100%
Liposome Stability
100%
Human Plasma
100%
Inductively Coupled Plasma Mass Spectrometry
100%
Capillary Electrophoresis
100%
Cisplatin
100%
Liposomal Formulation
42%
In Vitro Techniques
28%
Plasma Components
28%
Liposomes
28%
Liposomal
14%
Oxaliplatin
14%
In Vivo Drug Release
14%
Phospholipids
14%
Simultaneous Assessment
14%
Drug Release Profile
14%
Early Drug Development
14%
Disintegration
14%
PEGylated
14%
Encapsulation Efficiency
14%
Phospholipid Composition
14%
Triggered Release
14%
Physical Stability
14%
Simultaneous Monitoring
14%
Quality Control
14%
Complete Separation
14%
Pharmacology, Toxicology and Pharmaceutical Science
Capillary Electrophoresis
100%
Liposome
100%
Cisplatin
100%
Drug Release
100%
Inductively Coupled Plasma
100%
Phospholipid
28%
Drug Development
14%
Oxaliplatin
14%
Material Science
Platinum
100%
Plasma (Human)
100%
Inductively Coupled Plasma Mass Spectrometry
100%
Capillary Electrophoresis
100%
Phase Composition
25%